|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US6905680B2
(en)
|
1988-11-23 |
2005-06-14 |
Genetics Institute, Inc. |
Methods of treating HIV infected subjects
|
|
US6534055B1
(en)
|
1988-11-23 |
2003-03-18 |
Genetics Institute, Inc. |
Methods for selectively stimulating proliferation of T cells
|
|
US6352694B1
(en)
|
1994-06-03 |
2002-03-05 |
Genetics Institute, Inc. |
Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
|
|
US5858358A
(en)
|
1992-04-07 |
1999-01-12 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for selectively stimulating proliferation of T cells
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
US5283173A
(en)
|
1990-01-24 |
1994-02-01 |
The Research Foundation Of State University Of New York |
System to detect protein-protein interactions
|
|
WO1991014695A1
(en)
|
1990-03-22 |
1991-10-03 |
The Salk Institute For Biological Studies |
Insect retinoid receptor compositions and methods
|
|
EP0557459B1
(en)
|
1990-11-13 |
1997-10-22 |
Immunex Corporation |
Bifunctional selectable fusion genes
|
|
US5350674A
(en)
|
1992-09-04 |
1994-09-27 |
Becton, Dickinson And Company |
Intrinsic factor - horse peroxidase conjugates and a method for increasing the stability thereof
|
|
WO1994028143A1
(en)
|
1993-05-21 |
1994-12-08 |
Targeted Genetics Corporation |
Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
|
|
US7175843B2
(en)
|
1994-06-03 |
2007-02-13 |
Genetics Institute, Llc |
Methods for selectively stimulating proliferation of T cells
|
|
CA2213340C
(en)
|
1995-03-03 |
2011-07-26 |
Novartis Ag |
Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand
|
|
ES2201177T3
(es)
|
1995-03-08 |
2004-03-16 |
The Scripps Research Institute |
Sistema de presentacion de antigenos y activacion de celulas-t.
|
|
US7067318B2
(en)
|
1995-06-07 |
2006-06-27 |
The Regents Of The University Of Michigan |
Methods for transfecting T cells
|
|
US6692964B1
(en)
|
1995-05-04 |
2004-02-17 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for transfecting T cells
|
|
US5885827A
(en)
|
1996-01-23 |
1999-03-23 |
The Regents Of The Universtiy Of California |
Eukaryotic high rate mutagenesis system
|
|
CA2251466A1
(en)
|
1996-04-05 |
1997-10-16 |
The Salk Institute For Biological Studies |
Hormone-mediated methods for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
|
CA2254975C
(en)
|
1996-05-23 |
2008-12-16 |
The Scripps Research Institute |
Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells
|
|
WO1998040510A1
(en)
|
1997-03-11 |
1998-09-17 |
Regents Of The University Of Minnesota |
Dna-based transposon system for the introduction of nucleic acid into dna of a cell
|
|
AU738494B2
(en)
|
1997-07-10 |
2001-09-20 |
Salk Institute For Biological Studies, The |
Modified lepidopteran receptors and hybrid multifunctional proteins for use in regulation of transgene expression
|
|
US6333318B1
(en)
|
1998-05-14 |
2001-12-25 |
The Salk Institute For Biological Studies |
Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
|
US6790662B1
(en)
|
1999-03-12 |
2004-09-14 |
Ortho-Mcneil Pharmaceutical, Inc. |
Method of isolating CD8+ cells, and related hybridoma cells antibodies and polypeptides
|
|
AU1100201A
(en)
|
1999-10-28 |
2001-05-08 |
Board Of Trustees Of The Leland Stanford Junior University |
Methods of in vivo gene transfer using a sleeping beauty transposon system
|
|
US6867041B2
(en)
|
2000-02-24 |
2005-03-15 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
US6797514B2
(en)
|
2000-02-24 |
2004-09-28 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
DK1257632T3
(da)
|
2000-02-24 |
2008-01-28 |
Xcyte Therapies Inc |
Samtidig stimulering og opkoncentrering af celler
|
|
CN1304578C
(zh)
|
2000-03-22 |
2007-03-14 |
罗姆和哈斯公司 |
新的基于蜕皮激素受体的可诱导的基因表达系统
|
|
US20040033600A1
(en)
|
2001-03-21 |
2004-02-19 |
Palli Subba Reddy |
Ecdysone receptor-based inducible gene expression system
|
|
US8105825B2
(en)
|
2000-10-03 |
2012-01-31 |
Intrexon Corporation |
Multiple inducible gene regulation system
|
|
EP1534738B1
(en)
|
2001-02-20 |
2012-06-20 |
Intrexon Corporation |
Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
|
US20040071671A1
(en)
|
2001-02-20 |
2004-04-15 |
Leturcq Didier J. |
Cell therapy method for the treatment of tumors
|
|
JP4328094B2
(ja)
|
2001-02-20 |
2009-09-09 |
イントレクソン・コーポレイション |
新規置換突然変異体受容体および核受容体−ベースの誘導性遺伝子発現システムにおけるその使用
|
|
AU2002247184B2
(en)
|
2001-02-20 |
2008-06-19 |
Intrexon Corporation |
Novel ecdysone receptor/invertebrate retinoid X receptor-based inducible gene expression system
|
|
JP4955905B2
(ja)
|
2001-02-20 |
2012-06-20 |
イントレキソン コーポレーション |
キメラレチノイドｘ受容体および新規エクジソン受容体−ベースの誘導性遺伝子発現システムにおけるそれらの使用
|
|
AU2002257132A1
(en)
|
2001-04-06 |
2002-10-21 |
The Trustees Of The University Of Pennsylvania |
Erbb interface peptidomimetics and methods of use thereof
|
|
MXPA04002808A
(es)
|
2001-09-26 |
2005-06-06 |
Rheogene Holdings Inc |
Acidos nucleicos receptores de ecdisona de mosca blanca, polipeptidos, y sus usos.
|
|
EP1436394A4
(en)
|
2001-09-26 |
2004-12-29 |
Rheo Gene Holdings Inc |
CICADA ECDYSON RECEPTOR NUCLEIC ACIDS, POLYPEPTIDES AND THEIR USE
|
|
US7745140B2
(en)
|
2002-01-03 |
2010-06-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
|
|
US8227432B2
(en)
|
2002-04-22 |
2012-07-24 |
Regents Of The University Of Minnesota |
Transposon system and methods of use
|
|
US7569664B2
(en)
|
2002-10-09 |
2009-08-04 |
Immunocore Limited |
Single chain recombinant T cell receptors
|
|
US7985739B2
(en)
|
2003-06-04 |
2011-07-26 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enhanced sleeping beauty transposon system and methods for using the same
|
|
US7935510B2
(en)
|
2004-04-30 |
2011-05-03 |
Intrexon Corporation |
Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
|
ES2653570T3
(es)
|
2004-05-27 |
2018-02-07 |
The Trustees Of The University Of Pennsylvania |
Células presentadoras de antígeno artificiales novedosas y usos de las mismas
|
|
JP5563194B2
(ja)
|
2004-06-29 |
2014-07-30 |
イムノコア リミテッド |
改変ｔ細胞レセプターを発現する細胞
|
|
GB0523954D0
(en)
*
|
2005-11-24 |
2006-01-04 |
Ucb Celltech |
Bioassays
|
|
KR20080098066A
(ko)
|
2006-03-01 |
2008-11-06 |
얀센 파마슈티카 엔.브이. |
림프구 제거제를 ｃｔｌ 및 사이토카인과 결합한 암 치료
|
|
CA2655205A1
(en)
*
|
2006-06-12 |
2007-12-21 |
Receptor Biologix Inc. |
Pan-cell surface receptor- specific therapeutics
|
|
JP5543207B2
(ja)
|
2006-10-04 |
2014-07-09 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
不活性化された人工抗原提示細胞の調製および細胞治療におけるそれらの使用
|
|
JP2010520748A
(ja)
|
2007-02-20 |
2010-06-17 |
アナプティスバイオ インコーポレイティッド |
体細胞超変異系
|
|
AU2008271523B2
(en)
|
2007-07-04 |
2015-09-10 |
Max-Delbruck-Centrum Fur Molekulare Medizin |
Hyperactive variants of the transposase protein of the transposon system Sleeping Beauty
|
|
WO2009045370A2
(en)
|
2007-09-28 |
2009-04-09 |
Intrexon Corporation |
Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
|
|
CN101883845B
(zh)
|
2007-10-08 |
2015-06-10 |
英特瑞克斯顿股份有限公司 |
工程树突细胞及其在癌症治疗中的应用
|
|
WO2009054917A1
(en)
|
2007-10-19 |
2009-04-30 |
Amgen Inc. |
Methods of selecting epidermal growth factor receptor (egfr) binding agents
|
|
JP2012504959A
(ja)
|
2008-10-08 |
2012-03-01 |
イントレキソン コーポレーション |
複数の免疫モジュレーターを発現する遺伝子操作された細胞およびその使用
|
|
ES2911246T3
(es)
|
2009-11-03 |
2022-05-18 |
Hope City |
Receptor del factor de crecimiento epidérmico truncado (EGFRT) para selección de células T transducidas
|
|
JP2013527753A
(ja)
|
2010-03-23 |
2013-07-04 |
イントレキソン コーポレーション |
治療タンパク質を条件的に発現するベクター、該ベクターを含む宿主細胞およびそれらの使用
|
|
AU2011320314B2
(en)
*
|
2010-10-29 |
2015-08-06 |
Immunogen, Inc. |
Novel EGFR-binding molecules and immunoconjugates thereof
|
|
US9402919B2
(en)
|
2011-03-04 |
2016-08-02 |
Intrexon Corporation |
Vectors conditionally expressing protein
|
|
JP6850528B2
(ja)
*
|
2012-02-13 |
2021-03-31 |
シアトル チルドレンズ ホスピタル ドゥーイング ビジネス アズ シアトル チルドレンズ リサーチ インスティテュート |
二重特異性キメラ抗原受容体およびその治療的使用
|
|
KR20150010957A
(ko)
*
|
2012-04-25 |
2015-01-29 |
리가셉트, 엘엘씨 |
넓은 스펙트럼 erbb 리간드 결합 분자 및 그의 사용 방법
|
|
CN105122032B
(zh)
|
2013-03-12 |
2018-10-12 |
生物辐射实验室股份有限公司 |
胶体考马斯染剂
|
|
WO2014190273A1
(en)
|
2013-05-24 |
2014-11-27 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor-targeting monoclonal antibodies
|
|
CN104341504B
(zh)
*
|
2013-08-06 |
2017-10-24 |
百奥泰生物科技(广州)有限公司 |
双特异性抗体
|
|
SG11201604781RA
(en)
|
2013-12-18 |
2016-07-28 |
Intrexon Corp |
Single chain il-12 nucleic acids, polypeptids, and uses thereof
|
|
KR102375998B1
(ko)
|
2014-02-14 |
2022-03-21 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
키메라 항원 수용체 및 제조방법
|
|
AU2015270912B9
(en)
|
2014-06-02 |
2021-01-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric antigen receptors targeting CD-19
|
|
WO2016014565A2
(en)
|
2014-07-21 |
2016-01-28 |
Novartis Ag |
Treatment of cancer using humanized anti-bcma chimeric antigen receptor
|
|
AU2015296322B2
(en)
|
2014-07-26 |
2019-09-19 |
Sunshine Lake Pharma Co., Ltd. |
2-amino-pyrido[2,3-d]pyrimidin-7(8h)-one derivatives as CDK inhibitors and uses thereof
|
|
TWI805109B
(zh)
|
2014-08-28 |
2023-06-11 |
美商奇諾治療有限公司 |
對cd19具專一性之抗體及嵌合抗原受體
|
|
US20170291934A1
(en)
|
2014-09-22 |
2017-10-12 |
Charles C. Reed |
Improved therapeutic control of heterodimeric and single chain forms of interleukin-12
|
|
HK1243441A1
(zh)
|
2014-11-05 |
2018-07-13 |
Board Of Regents, The University Of Texas System |
基因修饰的免疫效应细胞和用於扩增免疫效应细胞的工程化细胞
|
|
EP3227323B1
(en)
|
2014-12-03 |
2020-08-05 |
Juno Therapeutics, Inc. |
Methods and compositions for adoptive cell therapy
|
|
CA2973529A1
(en)
|
2015-01-26 |
2016-08-04 |
Cellectis |
Cll1-specific multi-chain chimeric antigen receptor
|
|
AU2016334401A1
(en)
|
2015-10-10 |
2018-04-26 |
Intrexon Corporation |
Improved therapeutic control of proteolytically sensitive, destabilized forms of interleukin-12
|
|
ES2901795T3
(es)
|
2015-12-04 |
2022-03-23 |
Juno Therapeutics Inc |
Métodos y composiciones relacionadas con la toxicidad asociada con la terapia celular
|
|
US11787848B2
(en)
*
|
2016-06-08 |
2023-10-17 |
Precigen, Inc. |
CD33 specific chimeric antigen receptors
|
|
CN108330133B
(zh)
*
|
2017-01-20 |
2020-06-30 |
上海恒润达生生物科技有限公司 |
靶向cd19嵌合抗原受体并对其双重修饰的方法及其用途
|
|
US11149073B2
(en)
|
2017-04-28 |
2021-10-19 |
Julius-Maximilians-Universität Würzburg |
ROR1-specific chimeric antigen receptors (CAR) with humanized targeting domains
|